2 results
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Roflumilast) Indication ... Inhibitor GOLD 2019 ... Dosing: 250 mcg tablet ... COPD GOLD guidelines ... #Roflumilast #Indications
COPD Management Algorithm - GOLD 2019 guidelines 

Categorize into COPD GOLD A-D -> Initiate first-line therapy
COPD Management ... Algorithm - GOLD ... 2019 guidelines ... GOLD 2019 guidelines ... #Management #Pulmonary